Serum concentrations of SAA in relapsing-remitting MS patients have been reported elevated with a mean level of 12.1 ± 8.7 μg/ml [66], and significantly increased (mean value 10 μg/ml, p = 0.030 vs. control) in neuromyelitis optica patients [67]. This evidence concerns the gene SAA1 and neuromyelitis optica.